Evidence for a prospective anti-osteoporosis effect of black tea (Camellia Sinensis) extract in a bilaterally ovariectomized rat model

Asia Pacific Journal of Clinical Nutrition

Volumn 13, Issue 2, 2004, Pages 210-216

  Sekhar Das, Asankur ^a   Mukherjee, Maitrayee ^a   Mitra, Chandan ^a,b  

^a PRESIDENCY UNIVERSITY   (India)

^b NONE   (India)

Author keywords

Black tea extract; Bone density; Bone turnover; Osteoporosis; Ovariectomy

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BLACK TEA EXTRACT; CALCIUM; CREATININE; HYDROXYPROLINE; PHOSPHATE; WATER;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; BONE DENSITY; CALCIUM EXCRETION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FEMUR; KIDNEY MASS; LIVER WEIGHT; LUMBAR VERTEBRA; NONHUMAN; ORGAN WEIGHT; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; RANDOMIZATION; RAT; RIB; TEA; URINALYSIS; URINARY EXCRETION; UTERUS;

ANIMALS; BODY WEIGHT; BONE AND BONES; CAMELLIA SINENSIS; FEMALE; ORGAN SIZE; OSTEOPOROSIS; OVARIECTOMY; PLANT PREPARATIONS; RATS; TEA;

ANIMALIA; CAMELLIA; CAMELLIA SINENSIS;

EID: 3142559636     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. Dietary soybean protein prevents bone loss in an ovariectomized Rat model of Osteoporosis. J Nutr 1996; 126: 161-167.
2. Riis BJ. The role of bone turnover in the pathophysiology of osteoporosis. Br J Obstetrics Gynaecology May 1996; 103 (Suppl. 13): 9-15.
3. Mundy GR. Osteoporosis into the year 2010. Br J Obstetrics Gynaecology May 1996; 103 (Suppl. 13): 32-38.
4. Armstrong K, Popik S, Guerra C, Ubel PA. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. Med Decis Making July-Sept 2000; 20 (3): 308-313.
5. Khan A. Advances in osteoporosis therapy. 2003 update of practical guidelines. Can Fam Physician 2003; 49: 441-447.
6. Follin SL, Hansen LB. Current approaches to the prevention and treatment of postmenopausal osteoporosis. Am J Health Syst Pharm May 2003; 60 (9): 883-901.
7. Nieman LK. Management of surgically hypogonadal patients unable to take sex hormone replacement therapy. Endocrinol Metab Clin North Am Jun 2003; 32 (2): 325-36.
8. Krishnamoorthy KK. The nutritional and therapeutic value of tea. Proc International Symposium on Tea Science, Japan 1991: 6-11.
9. Fujita T. Osteoporosis in Japan: factors contributing to the low incidence of hip fracture. Adv Nutr Res 1994; 9: 89-99.
10. Kao PC, Peng FK. How to reduce the risk factors of osteoporosis in Asia. Chung Hua I Hsueh Tsa Chih (Taipei) March 1995; 55 (3): 209-213.
11. Hegarty VM, May HM, Khaw KT. Tea drinking and bone mineral density in older women. Am J Clin Nutr Apr 2000; 71 (4): 1003-1007.
12. Miksicek RJ. Commonly occurring plant flavonoids have ooestrogenic activity. Mol Pharmacol 1993; 44 (1): 37-43.
13. Toshiya T, Takehiko U, Kuniaki H, Haruo N, Kuniro T, Hitoshi I. New 6-0-Acylisoflavone glycosides from soybeans fermented with Bacillus subitilis (natto). I. 6-0-succinylated isoflavone glycosides and their preventive effects on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharma Bull 1999; 22 (11): 1193-1201.
14. Wattel A, Mentaverri R, Prouillet C, Mullie C, Dupont C, Kamel S, Brazier M. Effects of two flavonols, quercetin and kaempferol, on in vitro bone resorption and osteoclast apoptosis. Ann Nutr Metab 2001; 45: 217-234.
15. Lorenzetti S, Paterno A, Germani D, Cianfarani S, Branca F. Phytoooestrogens and IGF-1 in vitro regulation of bone resorption by osteoclasts. Ann Nutr Metab 2001; 45: 217-234.
16. Wei H, Zhang X, Zhao Ji-Fu, Wang ZY, Bickers D, Lebwohl M. Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas. Free Radical Biology and Medicine 1999; 26: (11/12) 1427-1435.
17. Nath RL, Nath RK. Practical Biochemistry in Clinical Medicine, 2nd edition. Calcutta: Academic Publishers, 1990; 8.
18. Chanda S, Islam MN, Parmanik P, Mitra C. High-lipid diet intake is a possible predisposing factor in development of hypogonadal osteoporosis. Jpn J Physiol 1996; 46 (5): 383-388.
19. Adeniyi KO, Ogunkeye OO, Isichei CO. Thyroidectomy and thyroxine administration alter serum calcium levels in rat. Acta Physiologica Hungarica 1993; 81 (1): 95-99.
20. Lowry HO, Lopez AJ. The determination of inorganic phosphate in the presence of labile phosphate esters. J Biol Chem 1946; 162: 421-428.
21. Nath RL, Nath RK. Practical Biochemistry in Clinical Medicine, 2nd edition. Calcutta: Academic Publishers, 1990: 94
22. Bergman I, Loxley R. The determination of hydroxyproline in urine hydrolysates. Clin Chim Actal 970; 27: 347-349.
23. Mitchell RH, Karnovsky MJ, Karnovsky MF. The distribution of some granule associated enzyme in guinea pig polymorphonuclear leucocyte. Biochem J 1970; 116: 207-216.
24. Yeh JK, Liu CC, Aloia JF. Effects of exercise and immobilization on bone formation and resorption in young rats. Am J Physiol (Endocrinol Metab. 27) 1993; 264: E 182-189.
25. Kalu DN, Liu CC, Salerno E, Hollis BW, Echon R, Ray M. Skeletal response of ovariectomized rats to low and high doses of 17 β-estradiol. Bone Miner 1991; 14: 175-187.
26. Weisburger JH. Tea antioxidants and health. In: Cadenas E, Packer L, eds. Handbook of Antioxidants. New York: Marcel Dekker Inc, 1996; 480.
27. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Eng J Med 1990; 323: 1-6.
28. Arjmandi BH, Liu CC, Yu S, Kalu DN. Effect of growth hormone on trabecular bone loss, Osteoclasts, Ostoblasts and their marrow progenitors. J Bone Miner Res 1994; 9 (1): S 382.
29. Kalu DN, Liu CC Arjmandi BH, Salerno E, Salih MA, Hollis BW. Growth hormone but not rhIGF-I reversed bone loss due to ovariectomy in rats. J Bone Min Res 1993; 8(Suppl. 1): S 271.
30. Turner CH. Toward a cure for Osteoporosis: reversal of excessive bone fragility. Osteoporosis Int 1991; 2: 12-19.
31. Lerner L, Turkhimer AR, Borman A. Phoretin, a weak oestrogen and oestrogen antagonist. Proc Soc Exp Boil Med 1963; 111: 115-117.
32. Christiansen C, Riss BJ, Rodbro P. Screening procedure for women at risk of developing post menopausal osteoporosis. Osteoporosis Int 1990; 1: 35-40.
33. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis. 12 year study. Br Med J 1991; 303: 961-964.
34. Hui SL, Slemenda CW, Johnston CC. The contribution of bone loss to postmenopausal osteoporosis. Osteoporosis Int 1990; 1: 30-34.
35. Christiansen C, Riis BJ, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; 1: 1105-1108.
36. Lindsay R, Coutts JRT, Hart DM. The effect of endogenous oestrogen on plasma and urinary calcium and phosphate in oophorectomized women. Clin Endocrinol 1977; 6: 87-93.
37. Myburgh KH, Noakes TD, Roodt M, Hough FS. Effect of exercise on the development of osteoporosis in adult rats. J Appl Physiol 1989; 66: 14-19.
38. Delmas PU. Biochemical markers of bone turnover. J Bone Miner Res 1993; 8: 5549-5555.
39. Gert BJ, Shao P, Hanson UA et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994; 9: 135-142.
40. Stepan JJ. Enzyme tests in bone disease. In: Moss DW, Rosalki SB, eds. Enzyme tests in diagnosis. New York: Oxford University Press Inc, 1996; 155-188.